Literature DB >> 11062593

Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?

M R Weir1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11062593     DOI： 10.1007/s11906-996-0030-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  8 in total

1.  Vitamin E supplementation and cardiovascular events in high-risk patients.

Authors:  S Yusuf; G Dagenais; J Pogue; J Bosch; P Sleight
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.

Authors:  L A Hebert; J W Kusek; T Greene; L Y Agodoa; C A Jones; A S Levey; J A Breyer; P Faubert; H A Rolin; S R Wang
Journal:  Hypertension       Date:  1997-09       Impact factor: 10.190

3.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

Authors:  G Viberti; C E Mogensen; L C Groop; J F Pauls
Journal:  JAMA       Date:  1994-01-26       Impact factor: 56.272

6.  Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Authors:  M Ravid; D Brosh; Z Levi; Y Bar-Dayan; D Ravid; R Rachmani
Journal:  Ann Intern Med       Date:  1998-06-15       Impact factor: 25.391

Review 7.  Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?

Authors:  M R Weir; L D Dworkin
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

8.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245
  8 in total
  1 in total

1.  Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.

Authors:  R Folgert G Haverdings; Marijke Haas; Gerjan Navis; Anne-Miek Van Loenen-Weemaes; Dirk K F Meijer; Dick De Zeeuw; Frits Moolenaar
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.